Literature DB >> 33767791

The effect of ketamine on preventing postpartum depression.

Mina Alipoor1, Marzeyeh Loripoor2, Majid Kazemi3, Farshid Farahbakhsh4, Ali Sarkoohi4.   

Abstract

Postpartum depression is a common disabling psychosocial disorder that could have adverse effects on the life of the mother, infant, and family. The present study was conducted to evaluate the effect of ketamine on preventing postpartum depression in women undergoing caesarian sections considering the relatively known positive effect of ketamine on major depression. The present double-blind, randomized clinical trial was conducted on 134 women undergoing scheduled caesarian sections. Participants were randomly allocated into two groups of control and intervention. To induce anesthesia, 1-2 mg/kg of body weight of Nesdonal and 0.5 mg/kg of body weight of ketamine were used in the intervention group, while only 3-5 mg/kg of body weight Nesdonal was administered in the control group. Data were gathered using the Edinburgh Postnatal Depression Scale (EPDS) in three stages: before the caesarian section and two and four weeks after the caesarian section. Data were analyzed using variance analysis with repeated measures and the Chi-square test. Results of the present study showed that the mean (± standard deviation) of the depression score in the intervention and control groups were 13.78±3.87 and 13.79±4.78(p = 0.98) before the caesarian section, 11.82±3.41 and 14.34±4.29 (p < 0.001) two weeks after and 10.84±3.48 and 13.09±3.79 (p = 0.001) four weeks after the caesarian section, respectively. Using ketamine in the induction of general anesthesia could be effective in preventing postpartum depression. However, further studies are required to strengthen these findings. ©2020 JOURNAL of MEDICINE and LIFE.

Entities:  

Keywords:  caesarian section; general anesthesia; ketamine; postpartum depression; prevention

Mesh:

Substances:

Year:  2021        PMID: 33767791      PMCID: PMC7982256          DOI: 10.25122/jml-2020-0116

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


  38 in total

1.  CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy.

Authors:  Anita J Bechtholt-Gompf; Karen L Smith; Catherine S John; Hannah H Kang; William A Carlezon; Bruce M Cohen; Dost Ongür
Journal:  Psychopharmacology (Berl)       Date:  2011-01-28       Impact factor: 4.530

2.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

Review 3.  Intravenous ketamine during spinal and general anaesthesia for caesarean section: systematic review and meta-analysis.

Authors:  M Heesen; J Böhmer; E C V Brinck; V K Kontinen; S Klöhr; R Rossaint; S Straube
Journal:  Acta Anaesthesiol Scand       Date:  2015-03-01       Impact factor: 2.105

Review 4.  How does ketamine elicit a rapid antidepressant response?

Authors:  Ege T Kavalali; Lisa M Monteggia
Journal:  Curr Opin Pharmacol       Date:  2014-11-25       Impact factor: 5.547

Review 5.  Psychiatric disorders during pregnancy.

Authors:  A D Cott; K L Wisner
Journal:  Int Rev Psychiatry       Date:  2003-08

6.  Does prenatal maternal stress impair cognitive development and alter temperament characteristics in toddlers with healthy birth outcomes?

Authors:  Peng Zhu; Meng-Sha Sun; Jia-Hu Hao; Yu-Jiang Chen; Xiao-Min Jiang; Rui-Xue Tao; Kun Huang; Fang-Biao Tao
Journal:  Dev Med Child Neurol       Date:  2014-01-20       Impact factor: 5.449

Review 7.  A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.

Authors:  A McGirr; M T Berlim; D J Bond; M P Fleck; L N Yatham; R W Lam
Journal:  Psychol Med       Date:  2014-07-10       Impact factor: 7.723

8.  New mothers' thoughts of harm related to the newborn.

Authors:  Nichole Fairbrother; Sheila R Woody
Journal:  Arch Womens Ment Health       Date:  2008-05-08       Impact factor: 3.633

Review 9.  Role of ketamine in acute postoperative pain management: a narrative review.

Authors:  Brian M Radvansky; Khushbu Shah; Anant Parikh; Anthony N Sifonios; Vanny Le; Jean D Eloy
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

Review 10.  Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide.

Authors:  Ronald S Duman
Journal:  F1000Res       Date:  2018-05-24
View more
  4 in total

1.  A randomized feasibility pilot-study of intravenous and subcutaneous administration of ketamine to prevent postpartum depression after planned cesarean delivery under neuraxial anesthesia.

Authors:  David Thomas Monks; Arvind Palanisamy; Danish Jaffer; Preet Mohinder Singh; Ebony Carter; Shannon Lenze
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-21       Impact factor: 3.105

2.  S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial.

Authors:  Yaqian Han; Pule Li; Mengrong Miao; Yuan Tao; Xia Kang; Jiaqiang Zhang
Journal:  BMC Anesthesiol       Date:  2022-02-16       Impact factor: 2.217

Review 3.  The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.

Authors:  Cindy A Stein; Andrew Penn; Stephanie Van Hope; Caroline G Dorsen; Mariavittoria Mangini
Journal:  J Midwifery Womens Health       Date:  2022-05-06       Impact factor: 2.891

Review 4.  Ketamine as a prophylactic resilience-enhancing agent.

Authors:  Audrey G Evers; James W Murrough; Dennis S Charney; Sara Costi
Journal:  Front Psychiatry       Date:  2022-07-28       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.